Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Establishment and Characterization of NCC-MFS5-C1: A Novel Patient-Derived Cell Line of Myxofibrosarcoma.

Cells - 8 Jan 2022

Tsuchiya Ryuto, Yoshimatsu Yuki, Noguchi Rei, Sin Yooksil, Ono Takuya, Akiyama Taro, Sugaya Jun, Kobayashi Eisuke, Kojima Naoki, Yoshida Akihiko, Ohtori Seiji, Kawai Akira, Kondo Tadashi

Abstract excerpt

Myxofibrosarcoma (MFS) is a highly aggressive malignancy with complex karyotypes and a postoperative recurrence tendency, owing to its strong invasiveness. Although systemic chemotherapy is considered in patients with unresectable MFS, the efficacy of conventional chemotherapy is hitherto unclear. Recently, drug screening analysis using a large number of tumor cell lines has been attempted to discover novel...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinogenesis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cell Culture Techniques

Share to Cell Survival

Share to Drug Screening Assays, Antitumor

Share to Fibrosarcoma

Share to Magnetic Resonance Imaging

Share to Mice, Nude

Source

Open in PubMed Open full text

Identifiers

PMID: 35053323
DOI: 10.3390/cells11020207
PMCID: PMC8773631

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Establishment and Characterization of NCC-MFS5-C1: A Novel Patient-Derived Cell Line of Myxofibrosarcoma.PMID 35053323Read ↗

Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1Semantic proximity Read ↗

Establishment and characterization of a novel patient-derived cell line from conventional central grade 3 chondrosarcoma, NCC-CS1-C1.Semantic proximity Read ↗

Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell lineSemantic proximity Read ↗

A Functional Precision Oncology Approach to Identify Treatment Strategies for Myxofibrosarcoma Patients.Semantic proximity Read ↗

The Biology of Myxofibrosarcoma: State of the Art and Future Perspectives.Semantic proximity Read ↗

Establishment and characterization of NCC-DSM1-C1: a novel cell line derived from a patient with desmoid fibromatosis.Semantic proximity Read ↗

Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.Semantic proximity Read ↗

Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1Semantic proximity Read ↗

Establishment and characterization of PUMC-DDCS1: a novel patient-derived cell line of dedifferentiated chondrosarcomaSemantic proximity Read ↗

Establishment of a novel cellular model for myxofibrosarcoma heterogeneity.Semantic proximity Read ↗

KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath tumorsSemantic proximity Read ↗

Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput ScreeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.